Mirtazapine

Mirtazapine

Nom du produit Mirtazapine
Numéro CAS 61337-67-5
Formule moléculaire C17H19N3
Poids moléculaire 265.35 g/mol
Apparence Poudre cristalline blanche à blanc cassé
Essai (HPLC) ≥ 99,01 TP3T
Perte au séchage ≤ 0,5%
Résidu au feu ≤ 0,11 TP3T
Métaux lourds ≤ 10 ppm
Colis 25 kg net in fiber drum with double polyethylene liner

Besoin d'aide ? Contacter notre équipe

Mirtazapine Structure

Synonymes : (±)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, Mirtazapine, Remeron, Zispin, Norset, Avanza, Mirtazapine API

Mirtazapine is a tetracyclic piperazino-azepine antidepressant that acts as an antagonist at central presynaptic α2-adrenergic autoreceptors and heteroreceptors. By blocking these receptors, it increases noradrenergic and serotonergic neurotransmission—a mechanism distinct from SSRIs and SNRIs. The molecule also shows potent antagonism at 5-HT2 and 5-HT3 receptors, plus significant antihistamine (H1) activity.

First approved in the mid-1990s, mirtazapine is now a standard treatment for major depressive disorder, often chosen when insomnia and appetite loss are prominent. It is available as immediate-release tablets and orally disintegrating tablets. The active pharmaceutical ingredient (API) is manufactured under cGMP and supplied in various particle sizes for solid dosage formulation.

Structure chimique et propriétés

Mirtazapine belongs to the chemical class of piperazino-azepines. Its structure features a fused tetracyclic ring system with a methylpiperazine moiety. The compound is a white to off-white crystalline powder, practically insoluble in water, but freely soluble in methanol and slightly soluble in ethanol. It exhibits no chiral center and is used as the racemate. The molecular formula is C17H19N3, and its molecular weight is 265.35 g/mol.

Mécanisme d'action

  • α2-adrenergic antagonism: Blocks presynaptic α2 autoreceptors and heteroreceptors, increasing release of norepinephrine and serotonin.
  • 5-HT2 receptor antagonism: Reduces serotonin-related side effects like insomnia and sexual dysfunction; contributes to anxiolytic effects.
  • 5-HT3 receptor antagonism: May reduce nausea and improve sleep architecture.
  • H1 histamine antagonism: Produces sedative effects, often beneficial for depressed patients with insomnia.

Spécifications de qualité

Paramètre Spécifications
Essai (HPLC) ≥ 99,01 TP3T
Perte au séchage ≤ 0,5%
Résidu au feu ≤ 0,11 TP3T
Métaux lourds ≤ 10 ppm
Granulométrie D90 ≤ 50 µm (customizable)
Solvants résiduels Meets ICH Q3C limits

Approvisionnement et documentation

  • Capacité: Capacité de production mensuelle de 500 kg, extensible sur demande.
  • Délai de livraison: 3 à 5 jours ouvrés (articles en stock)
  • Documentation: COA, MSDS, TDS, DMF available upon request.
  • Emballage: 25 kg fiber drums with double polyethylene liners; smaller quantities available.

Demande de devis

RESTEZ EN CONTACT

Demande de devis

Notre adresse

Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China

✅ ×